Delivery Order SPE2DB22D3010-SPE2DB25FP3EJ
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $5.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,140.38 to AmerisourceBergen Drug Corp for ProQuad vials on August 11, 2025, with a completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order supports federal medical procurement needs and is being performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order...
- The Defense Logistics Agency awarded a delivery order valued at $5,372.90 to AmerisourceBergen Drug Corp for ProQuad vials on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $5,062.32 delivery order to AmerisourceBergen Drug Corp for ProQuad vials under a firm fixed-price contract. The delivery order, which has an ultimate completion date of August 21, 2025, was awarded on July 31, 2025, with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine product, and this delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $2,686.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 14, 2025, with an ultimate completion date of September 5, 2025. This contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. ProQuad is a combination vaccine protecting against measles, mumps, rubella, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $1,670.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 12, 2025, with an ultimate completion date of September 3, 2025. This is an unset-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December...
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of ProQuad vials valued at $13,234.64 with a completion date of August 11, 2025. This non-competitive delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of ProQuad vials, a combination vaccine product. This firm fixed-price delivery order, valued at $1,687.48, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026. The order will be fulfilled from the contractor's...